相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy
Melissa M. Berrien-Elliott et al.
BLOOD (2022)
Double-negative T cells: Setting the stage for disease control or progression
Teresiama Velikkakam et al.
IMMUNOLOGY (2022)
A new immunotherapy strategy targeted CD30 in peripheral T-cell lymphomas: CAR-modified T-cell therapy based on CD30 mAb
Yang Wu et al.
CANCER GENE THERAPY (2022)
Decade-long leukaemia remissions with persistence of CD4(+) CAR T cells
J. Joseph Melenhorst et al.
NATURE (2022)
iPSC-Derived Natural Killer Cell Therapies-Expansion and Targeting
Benjamin H. Goldenson et al.
FRONTIERS IN IMMUNOLOGY (2022)
Allogeneic CD20-targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B-cell lymphoma models
Kevin P. Nishimoto et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2022)
Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy
Ramazan Rezaei et al.
CANCER GENE THERAPY (2022)
Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma
Mingzhi Zhang et al.
CLINICAL CANCER RESEARCH (2022)
Chimeric antigen receptor T cells for gamma-delta T cell malignancies
P. A. Wawrzyniecka et al.
LEUKEMIA (2022)
TCRαβ+ CD4−/CD8– “double negative” T cells in health and disease—implications for the kidney
Andrea M. Newman-Rivera et al.
KIDNEY INTERNATIONAL (2022)
A Simple and Robust Single-Step Method for CAR-Vδ1 γδT Cell Expansion and Transduction for Cancer Immunotherapy
Gabrielle M. Ferry et al.
FRONTIERS IN IMMUNOLOGY (2022)
Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies
Kamila Polgarova et al.
FRONTIERS IN ONCOLOGY (2022)
Allogeneic double-negative CAR-T cells inhibit tumor growth without off-tumor toxicities
Daniel Vasic et al.
SCIENCE IMMUNOLOGY (2022)
Phase I study of donor-derived CD5 CAR T cells in patients with relapsed or refractory T-cell acute lymphoblastic leukemia.
Jing Pan et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Treatment of aggressive T-cell lymphoma/leukemia with anti-CD4 CAR T cells
Jia Feng et al.
FRONTIERS IN IMMUNOLOGY (2022)
UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial
Reuben Benjamin et al.
LANCET HAEMATOLOGY (2022)
First in Human Study of AUTO4, a TRBC1-Targeting CAR T-Cell Therapy in Relapsed/Refractory TRBC1-Positive Peripheral T-Cell Lymphoma
Kate Cwynarski et al.
BLOOD (2022)
Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer
Yan Xu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Engineered off-the-shelf therapeutic T cells resist host immune rejection
Feiyan Mo et al.
NATURE BIOTECHNOLOGY (2021)
Exploring the NK cell platform for cancer immunotherapy
Jacob A. Myers et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Safety and Efficacy of Off-the-Shelf CD30.CAR-Modified Epstein-Barr Virus-Specific T Cells in Patients with CD30-Positive Lymphoma
David H. Quach et al.
BLOOD (2021)
A Novel and Successful Patient or Donor-Derived CD7-Targeted CAR T-Cell Therapy for Relapsed or Refractory T-Cell Lymphoblastic Lymphoma (R/R T-LBL)
Junfnag Yang et al.
BLOOD (2021)
CD30-Directed CAR-T Cells Co-Expressing CCR4 in Relapsed/Refractory Hodgkin Lymphoma and CD30+Cutaneous T Cell Lymphoma
Natalie S. Grover et al.
BLOOD (2021)
Development of Multi- Engineered iPSCDerived CAR-NK Cells for the Treatment of B-Cell Malignancies
Luis Borges et al.
BLOOD (2021)
Safety and Efficacy of FT596, a First-in-Class, Multi-Antigen Targeted, Off-the-Shelf, iPSC-Derived CD19 CAR NK Cell Therapy in Relapsed/Refractory B-Cell Lymphoma
Veronika Bachanova et al.
BLOOD (2021)
NK cell-based cancer immunotherapy: from basic biology to clinical development
Sizhe Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
HLA Class I Knockout Converts Allogeneic Primary NK Cells Into Suitable Effectors for Off-the-Shelf Immunotherapy
Keven Hoerster et al.
FRONTIERS IN IMMUNOLOGY (2021)
The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting
Yang Li et al.
FRONTIERS IN IMMUNOLOGY (2021)
CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?
Pouya Safarzadeh Kozani et al.
STEM CELL RESEARCH & THERAPY (2021)
Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
Nawid Albinger et al.
GENE THERAPY (2021)
The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy
Kellsye P. Fabian et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma
Amani Makkouk et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia
Caroline Duault et al.
BLOOD (2021)
Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors
Shuhang Wang et al.
BMC MEDICINE (2021)
CAR T-Cell Therapy in Hematological Malignancies
Theresa Haslauer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial
Jing Pan et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
Yan-Ruid Li et al.
CELL REPORTS MEDICINE (2021)
Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti-CD5 CAR T Cells
Jia Feng et al.
STEM CELL REVIEWS AND REPORTS (2021)
T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies
Valentina Cordo et al.
BLOOD CANCER DISCOVERY (2021)
Translating gammadelta (gamma delta) T cells and their receptors into cancer cell therapies
Zsolt Sebestyen et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
CD5 CAR T-Cells for Treatment of Patients with Relapsed/Refractory CD5 Expressing T-Cell Lymphoma Demonstrates Safety and Anti-Tumor Activity
LaQuisa Hill et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Potent Synergy between Combination of Chimeric Antigen Receptor (CAR) Therapy Targeting CD19 in Conjunction with Dendritic Cell (DC)/Tumor Fusion Vaccine in Hematological Malignancies.
Marzia Capelletti et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Human chimeric antigen receptor macrophages for cancer immunotherapy
Michael Klichinsky et al.
NATURE BIOTECHNOLOGY (2020)
Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR
Dana Stenger et al.
BLOOD (2020)
Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up
Joost H. van den Berg et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies
Keerthana Shankar et al.
STEM CELL RESEARCH & THERAPY (2020)
Leveraging Endogenous Dendritic Cells to Enhance the Therapeutic Efficacy of Adoptive T-Cell Therapy and Checkpoint Blockade
Mie Linder Hubbe et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cord-Blood Natural Killer Cell-Based Immunotherapy for Cancer
Xiaoyan Zhao et al.
FRONTIERS IN IMMUNOLOGY (2020)
Non-signaling Chimeric Antigen Receptors Enhance Antigen-Directed Killing by γδ T Cells in Contrast to αβ T Cells
Lauren C. Fleischer et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
CAR-NK cells: A promising cellular immunotherapy for cancer
Guozhu Xie et al.
EBIOMEDICINE (2020)
Phase I Study of Adoptive Immunotherapy with HA-1-Specific CD8+ and CD4+ Memory T Cells for Children and Adults with Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Trial in Progress
Elizabeth F. Krakow et al.
BLOOD (2020)
Safety and Efficacy of Ex Vivo Expanded Healthy Donor-Derived Double Negative T Cells for the Treatment of AML Relapsed after Allogeneic Stem Cell Transplantation: A First in-Human Phase I/IIa Clinical Trial
Tang Baolin et al.
BLOOD (2020)
Characterization of Donor Variability for γδ T Cell ex vivo Expansion and Development of an Allogeneic γδ T Cell Immunotherapy
Rebecca E. Burnham et al.
FRONTIERS IN MEDICINE (2020)
Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients
Mao Lin et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma
Daniela Di Blasi et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)
Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia
Diego Sanchez-Martinez et al.
BLOOD (2019)
T lymphocytes in the intestinal mucosa: defense and tolerance
Hongdi Ma et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade
Linan Fang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Targeting T Cell Malignancies Using CD4CAR T-Cells and Implementing a Natural Safety Switch
Gina Ma et al.
STEM CELL REVIEWS AND REPORTS (2019)
The Emerging World of TCR-T Cell Trials Against Cancer: A Systematic Review
Jianxiang Zhang et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2019)
Broad Cytotoxic Targeting of Acute Myeloid Leukemia by Polyclonal Delta One T Cells
Biagio Di Lorenzo et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Chimeric Antigen Receptors for T-Cell Malignancies
Lauren D. Scherer et al.
FRONTIERS IN ONCOLOGY (2019)
2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies
Yingxi Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies
Jinqi Huang et al.
LEUKEMIA (2019)
A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy
Rafijul Bari et al.
FRONTIERS IN IMMUNOLOGY (2019)
Developing Allogeneic Double-Negative T Cells as a Novel Off-the-Shelf Adoptive Cellular Therapy for Cancer
Jong Bok Lee et al.
CLINICAL CANCER RESEARCH (2019)
Targeting cancers through TCR-peptide/MHC interactions
Qinghua He et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Targeting T cell malignancies using CAR-based immunotherapy: challenges and potential solutions
Lauren C. Fleischer et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer
Bruno Silva-Santos et al.
NATURE REVIEWS CANCER (2019)
T-Cell Receptor-Based Immunotherapy for Hematologic Malignancies
Melinda A. Biernacki et al.
CANCER JOURNAL (2019)
Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies
Maksim Mamonkin et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Development of chimeric antigen receptors targeting T-cell malignancies using two structurally different anti-CD5 antigen binding domains in NK and CRISPR-edited T cell lines
Sunil S. Raikar et al.
ONCOIMMUNOLOGY (2018)
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Ye Li et al.
CELL STEM CELL (2018)
The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project
Monica Bellei et al.
HAEMATOLOGICA (2018)
Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy
Branson Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
An off-the-shelf fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies
Matthew L. Cooper et al.
LEUKEMIA (2018)
Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation
Anna Capsomidis et al.
MOLECULAR THERAPY (2018)
The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project
Monica Bellei et al.
HAEMATOLOGICA (2018)
Improving the Efficiency of Vγ9Vδ2 T Cell Immunotherapy in Cancer
Timm Hoeres et al.
FRONTIERS IN IMMUNOLOGY (2018)
Molecular Determinants of Target Cell Recognition by Human γδ T Cells
Andre E. Simoes et al.
FRONTIERS IN IMMUNOLOGY (2018)
Progress and Innovations in the Management of Adult Acute Lymphoblastic Leukemia
Elias Jabbour et al.
JAMA ONCOLOGY (2018)
Infusion of ex-vivo expanded human TCR-+ double-negative regulatory T cells delays onset of xenogeneic graft-versus-host disease
P. Achita et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell
Marco Ruella et al.
NATURE MEDICINE (2018)
CAR T-cells for T-cell malignancies: challenges in distinguishing between therapeutic, normal, and neoplastic T-cells
Marion Alcantara et al.
LEUKEMIA (2018)
Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas
Irene Scarfo et al.
BLOOD (2018)
Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms
JongBok Lee et al.
CLINICAL CANCER RESEARCH (2018)
Viral-specific T-cell transfer from HSCT donor for the treatment of viral infections or diseases after HSCT
C. Qian et al.
BONE MARROW TRANSPLANTATION (2018)
CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells
Xiaojuan Liu et al.
CELL RESEARCH (2017)
Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
Jiangtao Ren et al.
CLINICAL CANCER RESEARCH (2017)
Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes
Carlos A. Ramos et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor
K. H. Chen et al.
LEUKEMIA (2017)
HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
German G. Gornalusse et al.
NATURE BIOTECHNOLOGY (2017)
Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies
Paul M. Maciocia et al.
NATURE MEDICINE (2017)
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
Waseem Qasim et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Clonal selection in the human Vδ1 T cell repertoire indicates γδ TCR-dependent adaptive immune surveillance
Martin S. Davey et al.
NATURE COMMUNICATIONS (2017)
Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells
Kevin G. Pinz et al.
ONCOTARGET (2017)
Virus-Specific T Cells for the Immunocompromised Patient
Amy Houghtelin et al.
FRONTIERS IN IMMUNOLOGY (2017)
Tumor-infiltrating lymphocytes (TILs) from patients with glioma
Zhenjiang Liu et al.
ONCOIMMUNOLOGY (2017)
Blockade of CD7 expression in T cells for effective chimeric antigen receptor targeting of T-cell malignancies
Yi Tian Png et al.
BLOOD ADVANCES (2017)
RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma
Dennis C. Harrer et al.
BMC CANCER (2017)
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies
Diogo Gomes-Silva et al.
BLOOD (2017)
Double-Negative αβ T Cells Are Early Responders to AKI and Are Found in Human Kidney
Maria N. Martina et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Selection and expansion of natural killer cells for NK cell-based immunotherapy
Petra S. A. Becker et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Delta One T Cells for Immunotherapy of Chronic Lymphocytic Leukemia: Clinical-Grade Expansion/Differentiation and Preclinical Proof of Concept
Afonso R. Almeida et al.
CLINICAL CANCER RESEARCH (2016)
Harnessing NK Cell Memory for Cancer Immunotherapy
Todd A. Fehniger et al.
TRENDS IN IMMUNOLOGY (2016)
Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies
Kevin H. Chen et al.
ONCOTARGET (2016)
Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors
MacLean Hall et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Multiplex Genome-Edited T-cell Manufacturing Platform for Off-the-Shelf Adoptive T-cell Immunotherapies
Laurent Poirot et al.
CANCER RESEARCH (2015)
The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy
Mateusz Legut et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Challenges of cancer therapy with natural killer cells
Hans Klingemann
CYTOTHERAPY (2015)
Programmed Cell Death 1 and Helios Distinguish TCR-αβ+ Double-Negative (CD4-CD8-) T Cells That Derive from Self-Reactive CD8 T Cells
Noe Rodriguez-Rodriguez et al.
JOURNAL OF IMMUNOLOGY (2015)
Human Cytokine-Induced Memory-Like Natural Killer Cells
Melissa M. Berrien-Elliott et al.
JOURNAL OF INNATE IMMUNITY (2015)
AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody-Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML
Daniel S. Pereira et al.
MOLECULAR CANCER THERAPEUTICS (2015)
First-In-Patient Proof of Safety and Efficacy of a 4th Generation Chimeric Antigen Receptor-Modified T Cells for the Treatment of Relapsed or Refractory CD30 Positive Lymphomas
Zhi-Tao Ying et al.
MOLECULAR THERAPY (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
The production of alpha/beta and gamma/delta double negative (DN) T-cells and their role in the maintenance of pregnancy
John C. Chapman et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2015)
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
David L. Porter et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
HLA-G: An Immune Checkpoint Molecule
Edgardo D. Carosella et al.
ADVANCES IN IMMUNOLOGY, VOL 127 (2015)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Expanded human blood-derived γδT cells display potent antigen-presentation functions
Mohd Wajid A. Khan et al.
FRONTIERS IN IMMUNOLOGY (2014)
γδ T cell-mediated immune responses in disease and therapy
T. Sree Latha et al.
FRONTIERS IN IMMUNOLOGY (2014)
Donor haplotype B of NK KIR receptor reduces the relapse risk in HLA-icentical sibling hematopoetic stem cell transplantation of AML patients
Ulla Impola et al.
FRONTIERS IN IMMUNOLOGY (2014)
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study
Conrad Russell Y. Cruz et al.
BLOOD (2013)
Defining the nature of human gamma delta T cells: a biographical sketch of the highly empathetic
Shirin Kalyan et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cells
Inna V. Grishkan et al.
CELLULAR IMMUNOLOGY (2013)
Bispecific T-cells Expressing Polyclonal Repertoire of Endogenous γδ T-cell Receptors and Introduced CD19-specific Chimeric Antigen Receptor
Drew C. Deniger et al.
MOLECULAR THERAPY (2013)
Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies
Andrew S. Lee et al.
NATURE MEDICINE (2013)
Natural killer cells: a review of manufacturing and clinical utility
Scott A. Koepsell et al.
TRANSFUSION (2013)
Tumor cell recognition by γδ T lymphocytes T-cell receptor vs. NK-cell receptors
Daniel V. Correia et al.
ONCOIMMUNOLOGY (2013)
Antibody-dependent anti-cytomegalovirus activity of human γδ T cells expressing CD16 (FcγRIIIa)
Lionel Couzi et al.
BLOOD (2012)
Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset
Christelle Harly et al.
BLOOD (2012)
The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: a Children's Oncology Group report
Jay L. Patel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation
Martha Luevano et al.
HUMAN IMMUNOLOGY (2012)
Human Vγ9Vδ2 T Cells Specifically Recognize and Kill Acute Myeloid Leukemic Blasts
Julie Gertner-Dardenne et al.
JOURNAL OF IMMUNOLOGY (2012)
HLA-C-Dependent Prevention of Leukemia Relapse by Donor Activating KIR2DS1
Jeffrey M. Venstrom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
High-Throughput Sequencing Detects Minimal Residual Disease in Acute T Lymphoblastic Leukemia
David Wu et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions
Stephen C. Juvet et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2012)
Moving Successful Virus-specific T-cell Therapy for Hematopoietic Stem Cell Recipients to Late Phase Clinical Trials
Cliona Rooney et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2012)
Differentiation of human peripheral blood Vδ1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells
Daniel V. Correia et al.
BLOOD (2011)
IFN-γ enhances HOS and U2OS cell lines susceptibility to γδ T cell-mediated killing through the Fas/Fas ligand pathway
Zhaoxu Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Anti-leukemia effect of ex vivo expanded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapy
S. Merims et al.
LEUKEMIA (2011)
Characterization of CD3+CD4-CD8-(double negative) T cells reconstitution in patients following hematopoietic stem-cell transplantation
Haige Ye et al.
TRANSPLANT IMMUNOLOGY (2011)
Current progress in γδ T-cell biology
Jianlei Hao et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2010)
Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation
Ann M. Leen et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Bromohydrin Pyrophosphate-stimulated Vγ9δ2 T Cells Expanded Ex Vivo From Patients With Poor-Prognosis Neuroblastoma Lyse Autologous Primary Tumor Cells
Jamel Chargui et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Alloreactivity from human viral specific memory T-cells
L. J. A. D'Orsogna et al.
TRANSPLANT IMMUNOLOGY (2010)
γδ T cell effector functions: a blend of innate programming and acquired plasticity
Marc Bonneville et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Human TCR-αβ+ CD4- CD8- T Cells Can Derive from CD8+ T Cells and Display an Inflammatory Effector Phenotype
Jose C. Crispin et al.
JOURNAL OF IMMUNOLOGY (2009)
Characterization and immunotherapeutic potential of γδ T-cells in patients with glioblastoma
Nichole L. Bryant et al.
NEURO-ONCOLOGY (2009)
Double-negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation
Z. McIver et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
V gamma 9V delta 2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs - Rituximab and trastuzumab
Hirotake Tokuyama et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Both infiltrating regulatory T cells and insufficient antigen presentation are involved in long-term cardiac xenograft survival
Wenhao Chen et al.
JOURNAL OF IMMUNOLOGY (2007)
New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses
Dong Zhang et al.
BLOOD (2007)
Double-negative T regulatory cells can develop outside the thymus and do not mature from CD8+ T cell precursors
Megan S. Ford et al.
JOURNAL OF IMMUNOLOGY (2006)
Marker expression in peripheral T-cell lymphoma: A proposed clinical-pathologic prognostic score
Philip Went et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Donor lymphocyte infusion induces long-term donor-specific cardiac xenograft survival through activation of recipient double-negative regulatory T cells
WH Chen et al.
JOURNAL OF IMMUNOLOGY (2005)
Professional antigen-presentation function by human γδ T cells
M Brandes et al.
SCIENCE (2005)
TCR signal strength influences αβ/γδ lineage fate
SM Hayes et al.
IMMUNITY (2005)
Antigen recognition determinants of γδ T cell receptors
S Shin et al.
SCIENCE (2005)
Isolation and characterization of human antigen-specific TCRαβ+ CD4-CD8- double-negative regulatory T cells
K Fischer et al.
BLOOD (2005)
Determinants of antileukemia effects of allogeneic NK cells
W Leung et al.
JOURNAL OF IMMUNOLOGY (2004)
Inhibition of graft-versus-host disease by double-negative regulatory T cells
KJ Young et al.
JOURNAL OF IMMUNOLOGY (2003)
Role of double-negative regulatory T cells in long-term cardiac xenograft survival
WH Chen et al.
JOURNAL OF IMMUNOLOGY (2003)
Ex vivo expansion of the highly cytotoxic human natural killer cell line NK-92 under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy
YK Tam et al.
CYTOTHERAPY (2003)
Recognition mechanism of non-peptide antigens by human gamma delta T cells
S Yamashita et al.
INTERNATIONAL IMMUNOLOGY (2003)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Synthetic phosphoantigens enhance human Vγ9Vδ2 T lymphocytes killing of non-Hodgkin's B lymphoma
H Sicard et al.
MOLECULAR MEDICINE (2001)
Immunotherapy through TCR gene transfer
HWHG Kessels et al.
NATURE IMMUNOLOGY (2001)
Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes
LJN Cooper et al.
JOURNAL OF VIROLOGY (2000)